https://www.fiercebiotech.com/biotech/merck-buys-calporta-for-preclinical-neurodegeneration-assets
Merck buys Calporta for preclinical neurodegeneration assets | Fierce Biotech
Nov 13, 2019 - Merck has struck a deal to buy Calporta Therapeutics for up to $576 m
merckbuyspreclinicalneurodegenerationassets